Announcement | 10.21.22 PICI Network Researchers to Present at 2022 Annual Meeting of Society for Immunotherapy of Cancer #SITC22
Announcement | 09.28.22 PICI Welcomes Dana-Farber and Gladstone Institutes to its Network of Leading Experts Advancing Cures for Cancer
Announcement, Our Impact | 09.22.22 Parker Institute Researchers Highlighted at CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference #CICON22
Announcement, Our Impact | 09.09.22 PICI Network Researchers Featured at AACR Pancreatic Cancer Conference #AACRpan22
Announcement, Our Impact | 09.07.22 PICI Network Researchers to Present at ESMO Congress 2022 #ESMO22
Announcement, Our Impact | 09.02.22 PICI Network Researchers Featured at Cancer Research UK Brain Tumour Conference #CRUKBrain22
Announcement, Partner Highlight, Press Release | 08.24.22 LumaBridge and the Parker Institute for Cancer Immunotherapy Form Strategic Alliance to Speed Access to Clinical Trial Services for Partners
Announcement, Our Impact, Press Release | 07.27.22 Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers
Announcement, Partner Highlight, Press Release | 06.08.22 The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
Announcement, Press Release | 06.03.22 Biomarkers May Predict Better Immunotherapy Treatment Outcomes for Certain Patients with Pancreatic Cancer
Announcement, Press Release | 11.03.21 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Dosed in First-Line Pancreatic Cancer Platform Trial